Presented at ACC as a Late-Breaking Clinical Trial, VALOR-HCM explores Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive…
Dr. Lars Svensson, Chairman of the Sydell and Arnold Miller Heart and Vascular Institute discusses a recently published paper with Dr. Milind Desai, Medical Director of the Aorta Center, looking at a…
Steven Nissen, MD, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic discusses hypertrophic cardiomyopathy (HCM) with experts: cardiologist Milind…